Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Total Liabilities: 2010-2025

Historic Total Liabilities for SRx Health Solutions (SRXH) over the last 16 years, with Q3 2025 value amounting to $8.0 million.

  • SRx Health Solutions' Total Liabilities fell 9100.5% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 9100.5%. This contributed to the annual value of $8.0 million for FY2025, which is N/A changed from last year.
  • SRx Health Solutions' Total Liabilities amounted to $8.0 million in Q3 2025, which was down 9100.5% from $79.9 million recorded in Q2 2025.
  • SRx Health Solutions' 5-year Total Liabilities high stood at $88.9 million for Q3 2024, and its period low was $7.2 million during Q4 2024.
  • Moreover, its 5-year median value for Total Liabilities was $16.2 million (2023), whereas its average is $26.5 million.
  • The largest annual percentage gain for SRx Health Solutions' Total Liabilities in the last 5 years was 77312.78% (2025), contrasted with its biggest fall of 9100.5% (2025).
  • Over the past 5 years, SRx Health Solutions' Total Liabilities (Quarter) stood at $16.8 million in 2021, then grew by 2.16% to $17.1 million in 2022, then decreased by 19.76% to $13.8 million in 2023, then crashed by 48.01% to $7.2 million in 2024, then rose by 11.77% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $79.9 million for Q2 2025, and $7.3 million during Q1 2025.